The funding will support the expansion of Lasken AI’ healthcare data intelligence platform
- The investment closes the seed funding round in Croatian healthtech startup Lasken AI, alongside Fil Rouge Capital, backing the company’s expansion across Europe;
- Lasken AI is building a healthcare data intelligence platform that transforms publicly available healthcare information into continuously updated, structured datasets for healthcare organizations and pharmaceutical companies;
- Its customers include pharmaceutical and healthcare companies, healthtech firms, contract sales organizations, consultancies, and other service providers that rely on accurate, up-to-date market intelligence;
- GapMinder’s investment will support Lasken AI’s commercial rollout, initially targeting the German healthcare market before expanding into Europe’s five largest pharmaceutical markets.
Bucharest, July 22, 2026 – GapMinder, venture capital investing in technology startups from Romania and Eastern Europe, is leading a seed funding round in Croatian healthtech startup Lasken AI, alongside Fil Rouge Capital. Lasken AI is building a healthcare data intelligence platform that transforms publicly available healthcare information into continuously updated, structured datasets for pharmaceutical companies and healthcare organizations. Funding will support the expansion of Lasken AI’s proprietary healthcare data platform, further product development, and commercial growth across Europe.
Lasken AI connects 400,000 healthcare organizations in Germany, millions of healthcare professionals and more than half a trillion words from publicly available healthcare sources. By the end of 2026, this foundation is expected to expand to approximately 2.5 million healthcare organizations across Europe, creating the first consistent view of healthcare markets across multiple countries while preserving local market specificities. Lasken AI’s customers include: pharmaceutical and healthcare companies, healthtech firms, contract sales organizations, consultancies, and other service providers that rely on accurate, up-to-date market intelligence.
The investment adds to GapMinder’s growing portfolio of technology and AI-driven companies, including InsiderCX, Codeplain, Design Verse, SalesTools, VoicePatrol, and Etiq AI. With Lasken AI, GapMinder continues to expand its presence in the Croatian technology ecosystem, marking its second investment in a Croatian healthtech startup after InsiderCX.
“Healthcare is one of the largest and most complex industries in the world, yet many critical commercial decisions are still made using fragmented and outdated information. We believe Lasken AI is building the infrastructure needed to transform how healthcare organizations understand markets, identify opportunities, and engage with healthcare professionals. What stood out to us was the team’s deep healthcare expertise combined with a strong technology vision: creating a continuously evolving data foundation rather than another static database. We are excited to support their expansion across Europe and their ambition to become a key intelligence layer for the healthcare ecosystem”, says Cosmin Ochișor, Partner at GapMinder.
The company was founded by Patric Jarchow and Leonard Unger, who combine decades of healthcare expertise with extensive experience in building modern technology products.
Over more than two decades, Patric Jarchow has helped pharmaceutical and healthcare organizations improve commercial decision-making through better use of data. After founding several healthcare companies, he held international leadership roles at Merck and IQVIA, where he led initiatives in commercial excellence, go-to-market strategy, and digital innovation across global healthcare organizations. Leonard Unger has spent his career building startups, digital products and bringing new technologies to the finance and healthcare industry. They founded Lasken AI with the conviction that healthcare doesn’t need more data, but a stronger foundation for better decisions.
Unlike traditional datasets that provide static snapshots of markets, Lasken AI creates a living history of healthcare ecosystems. The platform tracks how healthcare organizations, professionals, and markets evolve over time, making changes visible and measurable. Beyond data collection, Lasken AI transforms this foundation into actionable intelligence. Customers receive ready-to-use insights, including target groups, market segments, site selections, and commercial recommendations, without having to build, integrate, or maintain complex datasets themselves.
For example, pharmaceutical companies can use Lasken AI to identify the pharmacies with the highest vaccination potential by analyzing vaccination service offerings across Germany and correlating them with local demographics, disease burden, vaccination rates, and other relevant healthcare indicators. Clients can also leverage the platform to generate intelligent physician target clusters, for example, oncology practices segmented by therapy spectrum, practice characteristics, socioeconomic environment, digital affinity, and other healthcare-specific data points.
“Every day, healthcare commercial teams search for answers to critical questions: where the biggest market opportunities are, which healthcare organizations to prioritize, or which sites are best positioned for clinical trials. The challenge is that this information is scattered across thousands of websites, databases, publications, and internal systems. Our vision with Lasken AI is to build the infrastructure that makes this information usable, acting as a digital librarian that continuously collects, organizes, and updates healthcare data to provide organizations with a clear and evolving view of the market. This fund allows us to accelerate our mission across Europe and help healthcare organizations navigate increasingly complex markets”, says Patric Jarchow, Co-founder and CEO of Lasken AI.
GapMinder’s investment will support Lasken AI’s rollout in Germany, establishing a strong foundation for further growth in the coming years. The company’s initial commercial focus will be on the German healthcare market, with plans to expand into Europe’s five largest pharmaceutical markets. In the long term, Lasken AI aims to make its Healthcare Data Foundation available across the continent.
The funding will also support the development of new capabilities in semantic understanding, organizational and market intelligence, persona building, and advanced commercial analytics. Lasken AI’s goal is to help healthcare organizations better understand markets, professionals, and opportunities, enabling smarter commercial decisions through a single trusted data foundation.
***
About Lasken AI
Lasken AI is creating the Healthcare Data Foundation for commercial Healthcare by transforming fragmented Healthcare information into one connected, continuously evolving foundation. Today, it connects around 400,000 Healthcare organizations, 2 million Healthcare professionals and more than 500 billion words of Healthcare information in Germany. By the end of the year, the foundation will expand across Europe to connect approximately 2.5 million Healthcare organizations. The foundation continuously connects Healthcare information, trusted Healthcare data products and customer data into one trusted source for better commercial decisions. As it grows over time, it creates a living history of the Healthcare market, making change visible instead of simply updating records. Instead of delivering isolated datasets, Lasken enables organizations to answer countless commercial questions from one trusted foundation. Customers use Lasken to identify opportunities, segment target groups, understand markets and make better commercial decisions through decision ready data products, APIs or dedicated Healthcare Data Foundations.
About Fil Rouge Capital
Fil Rouge Capital (FRC) is a venture capital firm based in Zagreb, serving as a primary architect for the region’s tech ecosystem. With over €100 million in Assets Under Management (AUM) and a track record of investing in more than 170 startups, FRC is one of the most active VC platforms in the Adriatic and Balkan regions. From its Zagreb headquarters, the firm bridges the funding gap from initial incubation to Series A, supporting over 300 founders. The firm remains sector-agnostic, targeting high-growth areas like AI, SaaS, and Fintech with investments ranging from €100,000 for early-stage prototypes to €4 million for scaling companies. By combining active funding with a “no-nonsense” mentorship approach and a vast global network, Fil Rouge Capital provides the essential infrastructure for local talent to achieve international success.
About GapMinder Ventures
GapMinder Ventures is a venture capital firm that invests in technology startups created in Romania and Eastern Europe (particularly in Croatia, Slovenia, Serbia, Bulgaria, and Moldova) that are in the seed or late seed phase and are rapidly expanding internationally. GapMinder takes a hands-on approach as an investor, helping companies with strategic advice and involvement in organizational scaling, financial discipline, corporate governance, and development. GapMinder manages two funds. With the first fund having a total capitalization of €50 million, GapMinder has invested in companies such as Druid.AI, FintechOS, Veridion, Deepstash, Siena.Cx, TypingDNA, Medicai, Cyscale, SmartDreamers, Machinations, Frisbo, and Innoship.io. GapMinder Fund II was launched in 2024 with a target capital of €80 million. The EIF supported GapMinder Fund II through two initiatives: the European Union’s InvestEU program and the Recovery Fund of Funds—part of the National Recovery and Resilience Plan, co-financed by the EU through Next GenerationEU. GapMinder Fund II is also supported by the EBRD and a number of institutional and private investors.
